Four JP Drafts Related to Balances Published for Public Comments
Recommendation
22/23 January 2025
Ensuring Control of Chromatographs, Integration and Results
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has announced the availability of four Japanese Pharmacopoeia (JP) drafts of General Tests and General Information related to Balances.
The following documents have been published on the PMDA website:
- Draft of revised General Test “<9.62> Measuring Instruments, Appliances”
- Draft of new General Information “<G1-6-182> Concept of Weighing in the Japanese Pharmacopoeia”
- Draft of new General Information “<G1-7-182> Calibration, Inspection, and Weight of a weighing instrument (balance)”
- Draft of new General Information “<G1-8-182> Installation Environment, Basic Handling Method, and Precautions for Weighing of a Balance”
The PMDA also published a Briefing Note in which the key points of these four drafts are summarised. It is pointed out that the drafts "were developed by referring to the content and requirements provided in United States Pharmacopeia and European Pharmacopoeia."
It is planned to include the chapters in Supplement II to the Japanese Pharmacopoeia 18th edition.
Comments can be submitted until 31 March 2023. For this purpose, a form for comments has to be downloaded and sent by e-mail after it has been filled in.
Related GMP News
15.01.2025English Translation of Supplement II to the Japanese Pharmacopoeia (JP18) Published
08.01.2025EDQM publishes new FAQ on System Suitability Test (SST)
08.01.2025Pharmeuropa Chapter 2.1.7. Balances for Analytical Purposes published for Comments
08.01.2025How to Guarantee a Complete FDA Inspection Failure
11.12.2024Another FDA Warning Letter Based on Review of Records